An elderly case whose residual malignant lymphoma was completely remitted by oral etoposide treatment using unusual dosing schedule
Soga, T.; Sakane, Y.; Fukuhara, S.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(3): 361-364
1997
ISSN/ISBN: 0385-0684 PMID: 9051141 Document Number: 483128
In a 72-year-old man with malignant lymphoma (Hodgkin's disease, nodular sclerosis type, Stage III S), complete remission was induced by intravenous drip of adriamycin and oral administration of etoposide. After that, a maintenance dose of etoposide (25 mg) was administered every 3 days without observable side effects. From these results, we considered that the dose level and interval of administration are both important for chemotherapy in elderly patients.
Document emailed within 1 workday
Related Documents
Moriya, A.; Ikeda, A.; Yokoyama, N.; Yokoyama, T.; Abe, Y.; Miyamoto, K. 1993: A case of gastric malignant lymphoma markedly responding to chronic daily and oral administration of low-dose etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2229-2233Yuki, K.; Kodama, Y.; Emoto, K.; Yukawa, O.; Onda, J.; Uozumi, T. 1989: A case report of advanced malignant mixed germ cell tumor of parasellar origin indicating marked efficacy of a salvage combined chemotherapy of CDDP and etoposide and subsequent chemotherapy using oral etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(8 Pt 1): 2651-2654
Goss, P.E.; Burkes, R.; Rudinskas, L.; King, M.; Chow, W.; Myers, R.; Davidson, M.; Poldre, P.; Crump, M.; Sutton, D. 1994: Prednisone, oral etoposide, and novantrone for treatment of non-Hodgkin's lymphoma: a preliminary report Seminars in Hematology 31(2 Suppl. 3): 23-29
Uysal, M.; Ozdogan, M.; Kargi, A.; Gunduz, S.; Sezgin Goksu, S.; Murat Tatli, A.; Arslan, D.; Mutlu, H.; Senol Coskun, H.; Bozcuk, H. 2014: Prolonged progression-free survival with maintenance metronomic oral cyclophosphamide and etoposide treatment in macroscopic residual disease or recurrent/advanced stage ovarian cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 19(4): 980-984
Takigawa, K.; Amino, Y.; Wakana, M.; Kobayashi, M.; Asada, Y.; Nagai, M.; Fujita, J.; Irino, S. 1990: An elderly case of small cell lung cancer showing complete response by oral administration of etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(1): 141-145
Ishikawa, S.; Shimizu, E.; Kawaji, K.; Mukai, J.; Tani, K.; Okubo, A.; Ogura, T.; Sano, T.; Yamashita, T. 1991: An elderly case of small cell lung cancer showing a good partial response by chronic daily administration of oral etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(1): 111-114
Izumi, T.; Muroi, K.; Hoshino, Y.; Komatsu, N.; Ohtsuki, T.; Yamada, M.; Tomizuka, H.; Hatake, K.; Furusawa, S.; Miura, Y. 1996: Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 797-800
Kitahara, S.; Murakuni, H.; Kudo, M.; Waki, K.; Hayashi, A.; Suzuki, T.; Tsugu, Y. 1987: Early combined carcinoma and malignant lymphoma in the stomach associated with tonsillar malignant lymphoma--report of a case Gan no Rinsho. Japan Journal of Cancer Clinics 33(11): 1379-1384
Whitacre, C.M.; Zborowska, E.; Gordon, N.H.; Mackay, W.; Berger, N.A. 1997: Topotecan increases topoisomerase IIalpha levels and sensitivity to treatment with etoposide in schedule-dependent process Cancer Research 57(8): 1425-1428
Jorizzo, J.L.; Carney, P.S.; Ko, W.T.; Robins, P.; Weinkle, S.H.; Werschler, W.P. 2004: Fluorouracil 5% and 0.5% creams for the treatment of actinic keratosis: equivalent efficacy with a lower concentration and more convenient dosing schedule Cutis 74(6 Suppl): 18-23
Karanti, A.; Landén, M. 2007: Treatment refractory psychosis remitted upon treatment with continuous positive airway pressure: a case report Psychopharmacology Bulletin 40(1): 113-117
Ishii, K.; Yamamoto, Y.; Shigeki, T.; Kitayama, H.; Hayashi, K.; Hirose, A.; Ohta, T.; Mugitani, A.; Fujino, H.; Yagi, T.; Hirai, M.; Teshima, H.; Katsurada, T.; Urase, F.; Kitajima, H. 2005: VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(1): 39-44
Hainsworth, J.D.; Johnson, D.H.; Greco, F.A. 1992: Chronic etoposide schedules in the treatment of non-Hodgkin's lymphoma Seminars in Oncology 19(6 Suppl 14: 13-18
Murakami, F.; Kiyozuka, Y.; Nishimura, H.; Imamura, K.; Yakushiji, M.; Noda, T.; Adachi, S.; Ito, K.; Tamori, N.; Shintani, M. 1993: Etoposide/cis-platinum (CDDP) combined chemotherapy for ovarian cancer: evaluation of optimum schedule for CDDP administration in chronic continuous exposure of ovarian cancer cells to low-dose etoposide in vitro Nihon Sanka Fujinka Gakkai Zasshi 45(2): 125-132
Zylberstein, D.; Röckert, L.; Roupe, G. 1987: An unusual skin manifestation in lymphocytic malignant lymphoma Lakartidningen 84(14): 1167-1168
Ando, B.; Inoue, K.; Koga, S.; Ibayashi, H.; Ando, S. 1986: An unresectable case of hepatoma completely disappearing after oral administration of an anticancer drug (UFT) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(11): 3261-3265
Grace, A.; O'Connell, N.; Byrne, P.; Prendiville, W.; O'Donnell, R.; Royston, D.; Walsh, C.B.; Leader, M.; Kay, E. 1999: Malignant lymphoma of the cervix. An unusual presentation and a rare disease European Journal of Gynaecological Oncology 20(1): 26-28
Uematsu, M.; Okada, M.; Ishii, N.; Watanabe, N.; Yasufuku, M. 1997: Surgical treatment of primary pulmonary malignant lymphoma: a report of successful case Kyobu Geka. Japanese Journal of Thoracic Surgery 50(4): 325-330
Low, Y.Yee.Sharon.; Lai, S.Hui.; Ng, W.Hoe. 2014: An unusual presentation of primary malignant B-cell-type dural lymphoma Singapore Medical Journal 55(11): E187-E190
Sobotkowski, J.; Błasińska-Morawiec, M.; Dowgier-Witczak, I. 2004: Vaginal bleeding as a first symptom of malignant lymphoma: case reports, diagnosis and successful treatment European Journal of Gynaecological Oncology 25(2): 245-246